Euthyroid Sick Syndrome: An Overview
The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Abnormalities of thyroid hormone concentrations are seen commonly in a wide variety of nonthyroidal illnesses, resulting in low triiodothyronine, total thyroxine, and thyroid stimulating hormone concentrations. These thyroid hormone changes may be mediated in part by cytokines or other inflammatory mediators, acting at the level of the hypothalamus and pituitary, the thyroid gland, and the hepatic deiodinase system, as well as on binding of thyroxine to thyroid binding globulin. The degree of thyroid function disturbance correlates with disease severity and low levels of thyroid hormones predict a poor prognosis in several illnesses. It remains unresolved whether the hormone responses in the euthyroid sick syndrome represent part of an adaptive response, which lowers tissue energy requirements in the face of systemic illness, or a maladaptive response, which induces damaging tissue hypothyroidism. Consequently, the use of thyroid hormone therapy in the euthyroid sick syndrome is controversial. The small number of controlled trials performed to date have shown conflicting results on the cardiovascular effects of triiodothyronine, and none has had the statistical power to address the question of altered mortality. Future trials of therapy should concentrate on patients with severe nonthyroidal illness and a high mortality rate. Meanwhile, better understanding is needed of the impact of the altered thyroid hormone status on tissue function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BRENT, G. A., & HERSHMAN, J. M. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-1-1 · Cited by 365
Tumor Necrosis Factor: A Putative Mediator of the Sick Euthyroid Syndrome in Man*
POLL, T. V. D., ROMIJN, J. A., WIERSINGA, W. M., & SAUERWEIN, H. P. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1567 · Cited by 270 · cited 1×
“Intravenous ad¬ ministration of TNF-into healthy volunteers (92) resulted in a 36% fall in T3, 48% rise in rT3, and 68% fall in TSH over a 12-h period.”
Suppression of Thyrotropin in the Low-Thyroxine State of Severe Nonthyroidal Illness
Wehmann, R. E., Gregerman, R. I., Burns, W. H., Saral, R., & Santos, G. W. (1985) · New England Journal of Medicine · doi:10.1056/nejm198502283120904 · Cited by 224
Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness.
Boelen, A., Platvoet-Ter Schiphorst, M. C., & Wiersinga, W. M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263160 · Cited by 196
Cardiopulmonary bypass and thyroid function: A “euthyroid sick syndrome”
Holland, F. W., Brown, P. S., Weintraub, B. D., & Clark, R. E. (1991) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(91)91416-s · Cited by 187
Kaptein, E. M., Robinson, W. J., Grieb, D. A., & Nicoloff, J. T. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110478 · Cited by 183
RELATIONSHIP OF ALTERED THYROID HORMONE INDICES TO SURVIVAL IN NONTHYROIDAL ILLNESSES
KAPTEIN, E. M., WEINER, J. M., ROBINSON, W. J., WHEELER, W. S., & NICOLOFF, J. T. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb03173.x · Cited by 167
PANG, X.-P., HERSHMAN, J. M., MIRELL, C. J., & PEKARY, A. E. (1989) · Endocrinology · doi:10.1210/endo-125-1-76 · Cited by 163
Thyroxine Metabolism in the Low Thyroxine State of Critical Nonthyroidal Illnesses*
KAPTEIN, E., GRIEB, D. A., SPENCER, C. A., WHEELER, W. S., & NICOLOFF, J. T. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-4-764 · Cited by 156
Bennett-Guerrero, E. (1996) · JAMA · doi:10.1001/jama.275.9.687 · Cited by 151
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Thyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899
“is found in patients with serious nonthyroidal illnesses.(40-43) These low levels of triiodothyronine are thought to be the consequence of a decreased conversion of thyroxine into triiodothyronine by a lower capacity or a lower amount of 5 selenodeiodinase in peripheral tissues due to disease-related factors.”
BackgroundDangerous dogmas in medicine: the nonthyroidal illness syndrome
De Groot, L. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5364 · Cited by 505
Thyroid hormones and their effects: a new perspective
HULBERT, A. J. (2000) · Biological Reviews of the Cambridge Philosophical Society · doi:10.1017/s146479310000556x · Cited by 396
Local activation and inactivation of thyroid hormones: the deiodinase family
Köhrle, J. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00040-4 · Cited by 341
The complex aetiology of cerebral palsy
Korzeniewski, S. J., Slaughter, J., Lenski, M., Haak, P., & Paneth, N. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0043-6 · Cited by 264
Peeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0535 · Cited by 251
“00/0 The Journal of Clinical Endocrinology & Metabolism 90(8):4559–4565 Printed in U.”
BackgroundInfluentialGereben, B., Zeöld, A., Dentice, M., Salvatore, D., & Bianco, A. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7396-0 · Cited by 207
De Groot, L. J. (2006) · Critical Care Clinics · doi:10.1016/j.ccc.2005.10.001 · Cited by 188
Cytokines and depression: fortuitous or causative association?
Dantzer, R., Wollman, E., Vitkovic, L., & Yirmiya, R. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000572 · Cited by 174
Plikat, K., Langgartner, J., Buettner, R., Bollheimer, L. C., Woenckhaus, U., Schölmerich, J., & Wrede, C. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.09.020 · Cited by 156
Tissue Thyroid Hormone Levels in Critical Illness
Peeters, R. P., van der Geyten, S., Wouters, P. J., Darras, V. M., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1013 · Cited by 145
“patients, T4 decreases, and both T4 and T3 are inversely correlated with mortality rate (2, 6).”
BackgroundFamilial Longevity Is Associated with Decreased Thyroid Function
Rozing, M. P., Houwing-Duistermaat, J. J., Slagboom, P. E., Beekman, M., Frölich, M., de Craen, A. J. M., Westendorp, R. G. J., & van Heemst, D. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0875 · Cited by 132
“This condition, referred to as nonthyroidal illness syndrome, is characterized by a variety of alterations in thyroid function parameters that commonly include low serum T3 along with normal or inappropriately low TSH and serum free T4 levels (14).”
BackgroundThyroid Hormones, Dementia, and Atrophy of the Medial Temporal Lobe
de Jong, F. J., den Heijer, T., Visser, T. J., de Rijke, Y. B., Drexhage, H. A., Hofman, A., & Breteler, M. M. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0449 · Cited by 129
A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome
Nagaya, T., Fujieda, M., Otsuka, G., Yang, J.-P., Okamoto, T., & Seo, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7771 · Cited by 107
Yu, J., & Koenig, R. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004866200 · Cited by 94
Jakobs, T. C., Schmutzler, C., Meissner, J., & Köhrle, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00288.x · Cited by 90
Regulation of Type 1 Iodothyronine Deiodinase in Health and Disease
Koenig, R. J. (2005) · Thyroid · doi:10.1089/thy.2005.15.835 · Cited by 90
Kleindienst, A., Brabant, G., Bock, C., Maser-Gluth, C., & Buchfelder, M. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0601 · Cited by 76
“The most rapid and consistent finding is a fall in circulating total T3 (i.e., low T3 syndrome), which is correlated with the severity of disease (Kaptein et al., 1982; McIver and Gorman, 1997).”
The hypothalamic-pituitary-thyroid axis in critical illness
Fliers, E., Alkemade, A., & Wiersinga, W. M. (2001) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2001.0163 · Cited by 69
Induction of Type 1 Iodothyronine Deiodinase to Prevent the Nonthyroidal Illness Syndrome in Mice
Yu, J., & Koenig, R. J. (2006) · Endocrinology · doi:10.1210/en.2005-1443 · Cited by 46
“Severe medical illness of any etiology is associated with the NTIS, the hallmark of which is a decreased level of circulating T3 (1, 2).”
BackgroundMönig, H., Arendt, T., Meyer, M., Kloehn, S., & Bewig, B. (1999) · Intensive Care Medicine · doi:10.1007/s001340051088 · Cited by 44
Nonthyroidal illness syndrome in enterocutaneous fistulas
Han, G., Ren, J., Liu, S., Gu, G., Ren, H., Yan, D., Chen, J., Wang, G., Zhou, B., Wu, X., et al. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2012.12.011 · Cited by 17
Metadata
- Authors
- McIVER, B., & GORMAN, C. A.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 1997-02
- Volume
- 7
- Issue
- 1
- Pages
- 125-132
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W2034049061
- Cited by
- 261
- References
- 79
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.